Parkinson’s disease is a progressive brain disorder that affects movement. More than 10 million people worldwide live with the condition.
Many people with Parkinson’s develop tremors, muscle stiffness, slow movements, and problems with balance.
As the disease progresses, walking often becomes one of the biggest challenges. Some people experience freezing of gait, a symptom in which their feet suddenly seem stuck to the ground. Others fall frequently and lose confidence in their ability to move around safely. These problems can greatly reduce independence and quality of life.
For many years, doctors have used a treatment called deep brain stimulation, or DBS, to help control some symptoms of Parkinson’s disease. DBS involves surgically implanting thin wires into specific parts of the brain. These wires are connected to a small device placed under the skin of the chest.
The device sends electrical signals into the brain and works somewhat like a pacemaker for the nervous system. Deep brain stimulation can be very effective for tremors, stiffness, and slow movement. However, many patients continue to struggle with walking difficulties and falls.
Researchers at the University of California, San Francisco, believed that one reason traditional DBS has limited effects on walking is that walking itself is constantly changing.
Every step requires complex communication between the brain, spinal cord, and muscles. Conventional DBS delivers the same pattern of stimulation all the time, regardless of whether a person is sitting, standing, or walking.
To solve this problem, the UCSF research team developed a new type of deep brain stimulation that can adjust itself in real time. The findings were published in the journal Nature Medicine.
The new system works by detecting brain signals associated with each step a person takes. The implanted device can then automatically change its stimulation within fractions of a second as the person moves.
The researchers compare the new system to a heart pacemaker. Just as a pacemaker responds to changes in the heart’s rhythm, this new brain stimulator responds to the brain’s rhythm of walking. Instead of providing the same electrical signals all day long, it adapts to the person’s movements moment by moment.
The study involved five people with Parkinson’s disease who had already undergone DBS surgery. In addition to their treatment electrodes, the participants received research electrodes placed over brain regions involved in movement.
These devices allowed scientists to identify each person’s unique brain signals during walking and program the stimulator to respond automatically.
The participants first completed laboratory testing. The adaptive system improved the symmetry of their walking and reduced variability in their movements. These changes are considered signs of a more stable and efficient walking pattern.
The participants then entered a blinded crossover study that lasted several days in their normal daily lives.
During periods when the adaptive stimulation system was turned on, the participants experienced fewer falls while maintaining good overall control of their Parkinson’s symptoms. The rapid changes in stimulation were well tolerated, and no serious side effects occurred.
The study marks an important advance because it shows that brain stimulation does not have to remain fixed. Instead, it can react to a person’s behavior in real time. Researchers believe this approach could eventually lead to treatments that respond not only to walking but also to speech, mood, thinking, and other brain functions.
The findings are exciting, but there are also limitations. The study involved only five participants, which is a very small number. Larger studies will be needed to confirm the benefits and determine whether the technology works well for a wider range of patients.
Researchers also need to understand how the system performs over longer periods and whether it can continue reducing falls over many years.
Even with these limitations, the study represents an important step toward a new generation of personalized brain therapies. The strength of the research lies in its ability to connect stimulation directly to a person’s movements instead of delivering the same treatment continuously.
If future studies confirm these findings, intelligent brain stimulators could transform how doctors treat Parkinson’s disease and possibly many other neurological conditions.
If you care about Parkinson’s disease, please read studies that Vitamin B may slow down cognitive decline, and Mediterranean diet could help lower risk of Parkinson’s.
For more health information, please see recent studies about how wheat gluten might be influencing our brain health, and Olive oil: a daily dose for better brain health..
Source: University of California, San Francisco.
